Streptococcus pneumoniae ('pneumococcus') causes an estimated 14.5 million cases of serious disease and 826,000 deaths annually in children under 5 years of age 1 . The highly effective introduction of the PCV7 pneumococcal vaccine in 2000 in the United States 2,3 provided an unprecedented opportunity to investigate the response of an important pathogen to widespread, vaccine-induced selective pressure. Here, we use array-based sequencing of 62 isolates from a US national monitoring program to study five independent instances of vaccine escape recombination 4 , showing the simultaneous transfer of multiple and often large (up to at least 44 kb) DNA fragments. We show that one such new strain quickly became established, spreading from east to west across the United States. These observations clarify the roles of recombination and selection in the population genomics of pneumococcus and provide proof of principle of the considerable value of combining genomic and epidemiological information in the surveillance and enhanced understanding of infectious diseases.
Childhood vaccination has proved effective against many viral and bacterial diseases, but more sophisticated vaccine approaches will be needed for pathogens with more complex genomes, life cycles and popu lation structures, with the evolutionary responses of organisms likely to be a key factor. Among the earliest successful bacterial vaccines were some for diseases (diphtheria and tetanus) where the actual cause of disease (for example, a toxin) was directly targeted. Conjugate vaccines, in which a bacterial polysaccharide is joined to an immunogenic protein, have been developed for two other important childhood patho gens, Haemophilus influenzae type B and Neisseria meningitidis type C [5] [6] [7] . The success of these vaccine strategies was, at least in part, due to the relatively simple structure of the pathogen population and the limited variability and evolvability of the pathogen molecule(s) targeted by the vaccine, but other organisms represent greater challenges. Pneumococcal cells are covered by a layer of polysaccharide called the capsule, which serves as a major virulence factor and provides a target for vaccination. The first pneumococcal conjugate vaccine in routine use in infants was PCV7 (Pfizer), a conjugate incorporating the polysaccharides of 7 of the >92 capsular types (serotypes), which was introduced in the United States in 2000 to immediate and dramatic effect. By 2001, rates of invasive pneumococcal disease in the vaccinated age group, 0-2 years, had decreased by 69% (ref. 2) , and by 2007, the rate in children under 5 years old had stabilized at 24% of the level present before the vaccine's inception 3 .
At the time of its introduction, there was considerable specula tion about the probable results of the extreme selection induced by the vaccine and its possible downstream consequences for vaccine efficacy and longevity 8, 9 . Colonization of the nasopharynx, especially in young children, provides the major reservoir for transmission of pneumococcus. Vaccination reduces the rate of colonization of PCV7 serotypes, interrupting transmission, while also allowing the rate of colonization by nonvaccine serotypes to increase 10 . Two mechanisms were anticipated for this serotype replacement: demographic expan sion of nonvaccine serotype lineages and capsular switching-the replacement of the capsular gene cluster in one genome by the non vaccine capsular genes from a different lineage.
We combined epidemiological and genomics approaches to better understand the nature, mechanisms and consequences of vaccine escape. We sequenced a preselected subset of 12% (300 kb) of the pneumococcus genome ( Supplementary Fig. 1 ) using Affymetrix CustomSeq technology and describe data from 62 isolates ascertained for potential epidemiological interest ( Table 1) . Wholegenome resequencing of several of the isolates on the Illumina Genome Analyzer IIx platform was used to confirm noteworthy findings.
During 2000-2007, approximately 27,000 sterilesite pneumo coccal isolates were recovered from infected individuals in ten US states and serotyped by the CDC as part of the Active Bacterial Core surveillance (ABCs) monitoring program 3 . The 'sequence type' of Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multifragment recombination event 1,902 serotype 19A isolates, collected between 2001 and 2007 from infected individuals of all ages, was then determined 4, 11, 12 by multi locus sequence typing (MLST), a widely used molecular fingerprint ing approach in which Sanger sequencing data are collected from seven fixed fragments of ~400-500 bp from essential genes 13 . Samples with a sequence type not commonly associated with serotype 19A represented potential examples of vaccine escape through capsular switching 14 (Table 1 ; details provided in Supplementary Table 1 ). We previously reported three distinct progeny strains, which we refer to as P1, P2 and P3, that resulted from capsular switching with serotype 4 recipients 4 , which we confirmed by Sanger sequencing to identify recombinational breakpoints. Two additional instances (P4 and P5) were identified in the current study by resequencing of candidate strains ( Supplementary Table 2 ). We have, therefore, defined a total of five independent instances of vaccine escape through capsular switches, in which serotype 4, which was included in the PCV7 vaccine, was replaced by serotype 19A, which was not in the vaccine.
In addition to identifying capsular switch recombinants, our resequencing approach allowed us to search for putative donor and recipient genomes. When one sequence incorporates DNA from another through recombination, we refer to the former as the recipient sequence and the latter as the donor sequence. For P1 and P2, our sequencing revealed that putative recipient and donor sequences were well matched with serotypes 4 and 19A, respectively. In addition, genomic analyses identified four and eight additional sequence fragments (for P1 and P2, respectively) that did not match known serotype 4 (recipient) genomes ( Fig. 1a,  Supplementary Fig. 2 and Supplementary  Table 3 ) and suggested that all imported fragments could have originated from a single serotype 19A donor sequence in each case. Illumina sequencing of an early P1 strain and its prospective donor and recipient confirmed our analysis and identified eight additional small imported fragments across the whole genome ( Fig. 1b) . To rule out the possibility that the additional fragments could have come from other serotype 4 sequences that we had not analyzed, we used SNP genotyping to screen 88 archived US serotype 4 isolates collected around the time PCV7 was introduced for matches to the P1 and P2specific additional sequence fragments, but we found no alternative candidate recipients that could explain the structure of P1 and P2 without invoking multiple imports from a serotype 19A-like donor (Supplementary Note and Supplementary Table 4 and 5).
Our data thus show the independent origin of each recombinant lineage and strongly support the idea that multiple fragments may be transferred during a single episode of recombination. Across P1-P5, conservative estimates suggest that a range of 1-27 fragments have been transferred in addition to the capsular locus, with sizes ranging from 0.04 to at least 44 kb ( Supplementary Table 3 ). Although it was impossible to exclude the possibility of separate sequential events in explaining each progeny structure, the observation that each capsular recombination event was accompanied by other serotype 19A-like imports elsewhere in the genome is strong evidence that multiple fragments may be imported from the donor simultaneously or in a short time sequence. Recombination involving transfer of large frag ments or multiple fragments simultaneously has long been observed or inferred in vitro in pneumococcus [15] [16] [17] [18] . A recent report docu mented multiple putative transfers in a single infected individual 19 . Our findings show that such recombination events can occur not only in vitro or in infected individuals but can also spread through a Representatives of recombinant P1 and its best-matching prospective parents were sequenced on the Illumina Genome Analyzer IIx platform. Sequence reads were assembled de novo and aligned to the TIGR4 reference sequence 22 , and a heuristic algorithm was implemented in which three or more donor-like single-nucleotide variants encompassing no more than one recipient-like variant were used to identify donor genomic fragments (blue, recipient; yellow, donor). This approach detected 15 imports of ≥50 bp, including 8 that did not overlap previously detected fragments. The scale in b is different from that in a because the reference sequences differ slightly. The smallest fragments (triangles) have been expanded to a minimum size of 5 kb for visibility. Sample IDs for each sequenced genome are in supplementary table 1. l e t t e r s population, becoming evident after a nationwide immunization program. Another recent report 20 detected several instances of capsu lar recombination in the 40year global spread of a multidrugresistant lineage of pneumococcus but did not give evidence for multifragment recombination, perhaps because of differences in sampling strategy or analytical methodology. Predictions made at the introduction of the pneumococcal conjugate vaccine in the United States about the potential for serotype replace ment were confirmed by early data from the ABCs network 2 . Among all nonvaccine serotypes, 19A has increased in frequency the most, for a variety of possible reasons 12 . Between 1998 and 2007, rates of invasive pneumococcal disease caused by serotype 19A increased by ~2.5fold, and its contribution to disease at all ages increased from approximately 3% to 20%, reaching 47% in children under the age of 5 (ref.
3) ( Fig. 2  and Supplementary Table 6 ). Capsular switching as a means of vaccine escape was also predicted in advance, but the success of the P1 vaccine escape lineage is still notable. Isolates were first detected in New York (n = 3) and Connecticut (n = 1) in 2003 (ref. 14) and have spread westward in subsequent years. Since 2003, P1 has become one of the most prevalent genotypes in postvaccine populations, having been recovered from 175 individuals of all ages by the end of 2007. In contrast, three of the other four vaccine escape lineages we detected, P3-P5, have been seen only once in our screen, and P2 has been observed eight times, predominantly in the northeastern United States.
The spread of the P1 vaccine escape recombinant and, to a lesser extent, P2 has also allowed us an unprecedented opportunity to observe pneumococcal evolution in real populations in real time. Genomic analyses of the evolution of the P1 and P2 lineages show that recombination events have continued to occur and imply that, when recombination can be definitively inferred, it tends to involve multiple genomic fragments (Supplementary Note and Supplementary Fig. 3) . With no ascertainment bias to favor recombination episodes involving a large transferred sequence, such as the capsular locus, these data are consistent with a model of variable numbers of smaller transferred sequences and with published estimates of the relative rates of recom bination and mutation 20, 21 . Depending on the assumptions made, the proportion of new variation within the P1 and P2 recombinant line ages that has arisen as a result of recombination can be estimated to be at least ~60% (details provided in the Supplementary Note).
In this study, we have observed, in five separate vaccine escape line ages and in the subsequent evolution of two of those lineages, 11 sepa rate episodes of recombination leading to the import of sequences into a pneumococcal genome. In only two of these episodes was there no evidence for transfer of multiple separate fragments, and, therefore, we conclude that multifragment recombination is commonplace in pneumococcal populations. One consequence of this finding is that even the terminology 'capsular switch' is potentially misleading, as it suggests that only the capsular locus has been transferred. l e t t e r s Documentation of multifragment recombination in real popula tions is particularly noteworthy because it has profound consequences for the way in which an organism may be able to traverse its evolu tionary fitness landscape. For example, moderatetohigh levels of βlactam class antimicrobial resistance are usually associated with horizontal transfer of variants at three dispersed pbp loci, and drug resistance required approximately two decades after the introduc tion of penicillin to first emerge in pneumococcus. Having emerged, penicillin resistance determinants now spread rapidly from one genetic background to another under druginduced selective pressure and pose a significant threat to treatment. Multifragment recombi nation could also have been important in generating the currently unknown factor(s) that allowed P1 to surpass many other nonvaccine lineages in invasive disease incidence. The recent introduction of a 13valent pneumococcal conjugate vaccine including serotype 19A in the United States and elsewhere is likely to significantly reduce the impact of serotype 19A on vaccinated populations, but how many and which serotypes will be needed for a vaccine that provides acceptable longterm disease reduction are still unknown.
Modern highthroughput molecular technologies now allow typing of bacterial isolates on a genomic scale, thus providing much greater resolution than the standard MLST approaches currently used. We have described a proofofprinciple experiment that con firms the potential for combining genomescale genetic information with epidemiological data, in this case to better understand sero type replacement following the introduction of a conjugate vaccine. We identified five independent instances of vaccine escape through capsular switching from serotype 4 to 19A. Our genomic data provide strong evidence that, in each case, the recombination event gener ating the capsular switch involved simultaneous import of multiple and often large additional DNA fragments from locations across the genome. This process has farreaching consequences for the evolu tion of bacteria and their response to the strong selection imposed by vaccines or antimicrobials. It may also have a role in the notable success of the P1 vaccine escape lineage as an invasive pathogen among the 19A lineages present after vaccine introduction. Although vaccine escape through capsular switching was correctly predicted in advance of the vaccination program, our analyses show that, particularly in light of complex recombination mechanisms, its specific consequences are difficult to predict.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
